
Metastatic Breast Cancer/LinkedIn
Dec 14, 2024, 06:34
Immediate Subsequent lines of therapy after T-DXd in Metastatic Breast Cancer – Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X:
“SABCS24 POSTER SESSION | P1-08-08 |
Real-world efficacy of immediate subsequent lines of therapy after trastuzumab deruxtecan (T-DXd) in patients with Metastatic Breast Cancer (MBC) – retrospective study from the nationwide Flatiron database.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 10:07
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07